To get an impression of the frequency of anti-TSPY antibodies, the sera of 106 HCC patients and 46 healthy controls were tested for Ab reactivity against recombinant TSPY by Western blot (Figure 4). Here, TSPY1 is linked to hepatocellular carcinoma.